Cipher Pharmaceuticals
Cipher Pharmaceuticals is a specialty pharmaceutical company with a diverse portfolio of commercial and developmental products, focusing on unmet medical needs and strategic partnerships.
Services
Cipher Pharmaceuticals specializes in identifying and acquiring products that meet unmet medical needs. The company oversees the clinical development and regulatory approval process necessary for launching these products. Cipher markets its products directly in Canada and through partnerships in the U.S. and South America. The company also engages in out-licensing and in-licensing products and makes selective investments in drug development to build a broad portfolio of prescription offerings.
Products
Cipher Pharmaceuticals markets a wide range of products in multiple therapeutic areas, including dermatology, gastrointestinal, women's health, CNS, urology, immunology, ophthalmology, cardiology, hepatology, and respiratory. Notable products include Actikerall® for hyperkeratotic actinic keratosis, Epuris® for severe acne, Vaniqa® for unwanted facial hair in women, and Durela® for moderate to moderately severe pain. Cipher's portfolio also includes Aggrastat® for Acute Coronary Syndrome and Brinavess® for atrial fibrillation.
Product Pipeline
Cipher Pharmaceuticals has a diversified product pipeline with Phase III studies ongoing for two product candidates. The company holds exclusive Canadian license rights for MOB-015, used to treat nail fungus, and CF-101 for moderate to severe plaque psoriasis. Additionally, Cipher has global rights for DTR-001, a tattoo removal treatment, which adds to their robust selection of development-stage assets.
Marketing and Partnerships
Cipher Pharmaceuticals enhances its market reach through strategic partnerships. In the U.S., it markets Absorica® for severe acne through Sun Pharmaceuticals, ConZip® for chronic pain via Vertical Pharmaceuticals, and Lipofen® for lipid reduction with Ani Pharmaceuticals. These partnerships help Cipher generate substantial royalty revenue from successful product lines globally.
Therapeutic Areas
Cipher Pharmaceuticals operates in various therapeutic areas, including dermatology, gastrointestinal, women's health, CNS, urology, immunology, ophthalmology, cardiology, hepatology, and respiratory. This diversified focus allows the company to address multiple unmet medical needs with a range of specialized products, enhancing its market presence and providing comprehensive healthcare solutions.